Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair

BACKGROUND: Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects of enhancing cancer cell radiosensitivity. PRINCIPAL FINDING: Lung cancer A549 cells and breast cancer MCF-7 cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yuan-yuan, Hu, Song-liu, Xu, Xiang-ying, Wang, Rui-zhi, Yu, Hong-yang, Xu, Jian-yu, Chen, Lin, Dong, Guang-lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745376/
https://www.ncbi.nlm.nih.gov/pubmed/23976954
http://dx.doi.org/10.1371/journal.pone.0070727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745376/
https://www.ncbi.nlm.nih.gov/pubmed/23976954
http://dx.doi.org/10.1371/journal.pone.0070727

Ejemplares similares